Chronic obstructive pulmonary disease and asthma-associated Proteobacteria, but not commensal Prevotella spp., promote Toll-like receptor 2-independent lung inflammation and pathology

Immunology

Volumn 144, Issue 2, 2015, Pages 333-342

  Larsen, Jeppe M ^a   Musavian, Hanieh S ^a   Butt, Tariq M ^a   Ingvorsen, Camilla ^a   Thysen, Anna H ^a   Brix, Susanne ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

Asthma; Chronic obstructive pulmonary disease; Lung immunopathology; Microbiota; Respiratory inflammation

Indexed keywords

CHEMOKINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 5; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; THYMIC STROMAL LYMPHOPOIETIN; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; TLR2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BACTERIAL COLONIZATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMENSAL; CONTROLLED STUDY; GRAM NEGATIVE BACTERIUM; HAEMOPHILUS INFLUENZAE TYPE B; IMMUNE SYSTEM; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; LUNG PARENCHYMA; MORAXELLA CATARRHALIS; MOUSE; NEUTROPHILIA; NONHUMAN; NONTYPEABLE HAEMOPHILUS INFLUENZAE; PREVOTELLA; PREVOTELLA MELANINOGENICA; PREVOTELLA NANCEIENSIS; PREVOTELLA SALIVAE; PRIORITY JOURNAL; PROTEOBACTERIA; RESPIRATORY TRACT INFLAMMATION; ANIMAL; BACTEROIDACEAE INFECTION; C57BL MOUSE; HAEMOPHILUS INFECTION; HUMAN; IMMUNOLOGY; INFLAMMATION; LUNG; MICROBIOLOGY; MORAXELLACEAE INFECTION; NEUTROPHIL; PATHOLOGY; SYMBIOSIS;

ANIMALS; ASTHMA; BACTEROIDACEAE INFECTIONS; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HUMANS; INFLAMMATION; LUNG; MICE; MICE, INBRED C57BL; MORAXELLA (BRANHAMELLA) CATARRHALIS; MORAXELLACEAE INFECTIONS; NEUTROPHILS; PREVOTELLA; PROTEOBACTERIA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SYMBIOSIS; TOLL-LIKE RECEPTOR 2;

EID: 84922526995     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12376     Document Type: Article

References (55)

1. Maynard CL, Elson CO, Hatton RD, Weaver CT. Reciprocal interactions of the intestinal microbiota and immune system. Nature 2012; 489:231-41.
2. Kamada N, Seo S-U, Chen GY, Núñez G. Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol 2013; 13:321-35.
3. Tremaroli V, Bäckhed F. Functional interactions between the gut microbiota and host metabolism. Nature 2012; 489:242-9.
4. Kahn FW, Jones JM. Diagnosing bacterial respiratory infection by bronchoalveolar lavage. J Infect Dis 1987; 155:862-9.
5. Baughman R, Thorpe J, Staneck J, Rashkin M, Frame P. Use of the protected specimen brush in patients with endotracheal or tracheostomy tubes. Chest 1987; 91:233-6.
6. Thorpe JE, Baughman RP, Frame PT, Wesseler TA, Staneck JL. Bronchoalveolar lavage for diagnosing acute bacterial pneumonia. J Infect Dis 1987; 155:855-61.
7. Hilty M, Burke C, Pedro H et al. Disordered microbial communities in asthmatic airways. PLoS One 2010; 5:e8578.
8. Charlson ES, Chen J, Custers-Allen R et al. Disordered microbial communities in the upper respiratory tract of cigarette smokers. PLoS One 2010; 5:e15216.
9. Erb-Downward JR, Thompson DL, Han MK et al. Analysis of the lung microbiome in the "healthy" smoker and in COPD. PLoS One 2011; 6:e16384.
10. Harris JK, De Groote MA, Sagel SD et al. Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis. Proc Natl Acad Sci U S A 2007; 104:20529-33.
11. Charlson ES, Bittinger K, Haas AR, Fitzgerald AS, Frank I, Yadav A, Bushman FD, Collman RG. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am J Respir Crit Care Med 2011; 184:957-63.
12. Nagy E. Anaerobic infections: update on treatment considerations. Drugs 2010; 70:841-58.
13. Brook I. Anaerobic pulmonary infections in children. Pediatr Emerg Care 2004; 20:636-40.
14. Brook I. Microbiology of common infections in the upper respiratory tract. Prim Care 1998; 25:633-48.
15. Littman DR, Pamer EG. Role of the commensal microbiota in normal and pathogenic host immune responses. Cell Host Microbe 2011; 10:311-23.
16. Goleva E, Jackson LP, Harris JK et al. The effects of airway microbiome on corticosteroid responsiveness in asthma. Am J Respir Crit Care Med 2013; 188:1193-201.
17. Bisgaard H, Hermansen MN, Buchvald F et al. Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med 2007; 357:1487-95.
18. Murphy TF, Sethi S, Niederman MS. The role of bacteria in exacerbations of COPD. A constructive view. Chest 2000; 118:204-9.
19. Monsó E, Rosell A, Bonet G, Manterola J, Cardona PJ, Ruiz J, Morera J. Risk factors for lower airway bacterial colonization in chronic bronchitis. Eur Respir J 1999; 13:338-42.
20. Zalacain R, Sobradillo V, Amilibia J, Barrón J, Achótegui V, Pijoan JI, Llorente JL. Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease. Eur Respir J 1999; 13:343-8.
21. Papi A, Luppi F, Franco F, Fabbri LM. Pathophysiology of exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006; 3:245-51.
22. Hill AT, Campbell EJ, Hill SL, Bayley DL, Stockley RA. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med 2000; 109:288-95.
23. Wilkinson TMA, Patel IS, Wilks M, Donaldson GC, Wedzicha JA. Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2003; 167:1090-5.
24. Sethi S, Maloney J, Grove L, Wrona C, Berenson CS. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173:991-8.
25. Albert RK, Connett J, Bailey WC et al. Azithromycin for prevention of exacerbations of COPD. N Engl J Med 2011; 365:689-98.
26. Bisgaard H, Hermansen MN, Bønnelykke K et al. Association of bacteria and viruses with wheezy episodes in young children: prospective birth cohort study. BMJ 2010; 341:c4978.
27. Larsen JM, Brix S, Thysen AH, Birch S, Rasmussen MA, Bisgaard H. Children with asthma by school age display aberrant immune responses to pathogenic airway bacteria as infants. J Allergy Clin Immunol 2014; 133:1008-1013.e4.
28. Gaschler GJ, Skrtic M, Zavitz CCJ, Lindahl M, Onnervik P-O, Murphy TF, Sethi S, Stämpfli MR. Bacteria challenge in smoke-exposed mice exacerbates inflammation and skews the inflammatory profile. Am J Respir Crit Care Med 2009; 179:666-75.
29. Gaschler GJ, Zavitz CCJ, Bauer CMT, Stämpfli MR. Mechanisms of clearance of nontypeable Haemophilus influenzae from cigarette smoke-exposed mouse lungs. Eur Respir J 2010; 36:1131-42.
30. Moghaddam SJ, Clement CG, De la Garza MM et al. Haemophilus influenzae lysate induces aspects of the chronic obstructive pulmonary disease phenotype. Am J Respir Cell Mol Biol 2008; 38:629-38.
31. Bonefeld CM, Larsen JM, Dabelsteen S, Geisler C, White IR, Menné T, Johansen JD. Consumer available permanent hair dye products cause major allergic immune activation in an animal model. Br J Dermatol 2010; 162:102-7.
32. Dyer KD, Garcia-Crespo KE, Killoran KE, Rosenberg HF. Antigen profiles for the quantitative assessment of eosinophils in mouse tissues by flow cytometry. J Immunol Methods 2011; 369:91-7.
33. Pittman M. Variation and type specificity in the bacterial species Haemophilus influenzae. J Exp Med 1931; 53:471-92.
34. Geme JWS. Molecular and cellular determinants of non-typeable Haemophilus influenzae adherence and invasion. Cell Microbiol 2002; 4:191-200.
35. Keatings VM, Collins PD, Scott DM, Barnes PJ. Differences in interleukin-8 and tumor necrosis factor-α in induced sputum from patients with chronic obstructive pulmonary disease or asthma. Am J Respir Crit Care Med 1996; 153:530-4.
36. Soumelis V, Reche PA, Kanzler H et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 2002; 3:673-80.
37. Chung KF. Cytokines in chronic obstructive pulmonary disease. Eur Respir J Suppl 2001; 34:50s-9s.
38. + cells correlates with chronic obstructive pulmonary disease severity. Am J Pathol 2007; 171:767-76.
39. Elson G, Dunn-Siegrist I, Daubeuf B, Pugin J. Contribution of Toll-like receptors to the innate immune response to Gram-negative and Gram-positive bacteria. Blood 2007; 109:1574-83.
40. Alhawi M, Stewart J, Erridge C, Patrick S, Poxton IR. Bacteroides fragilis signals through Toll-like receptor (TLR) 2 and not through TLR4. J Med Microbiol 2009; 58:1015-22.
41. Larsen JM, Steen-Jensen DB, Laursen JM, Søndergaard JN, Musavian HS, Butt TM, Brix S. Divergent pro-inflammatory profile of human dendritic cells in response to commensal and pathogenic bacteria associated with the airway microbiota. PLoS One 2012; 7:e31976.
42. Bäckhed F, Normark S, Schweda EKH, Oscarson S, Richter-Dahlfors A. Structural requirements for TLR4-mediated LPS signalling: a biological role for LPS modifications. Microbes Infect 2003; 5:1057-63.
43. Miller SI, Ernst RK, Bader MW. LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol 2005; 3:36-46.
44. Lebeer S, Vanderleyden J, De Keersmaecker SCJ. Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat Rev Microbiol 2010; 8:171-84.
45. Caroff M, Karibian D. Structure of bacterial lipopolysaccharides. Carbohydr Res 2003; 338:2431-47.
46. Caroff M, Karibian D, Cavaillon JM, Haeffner-Cavaillon N. Structural and functional analyses of bacterial lipopolysaccharides. Microbes Infect 2002; 4:915-26.
47. Schweda EKH, Twelkmeyer B, Li J. Profiling structural elements of short-chain lipopolysaccharide of non-typeable Haemophilus influenzae. Innate Immun 2008; 14:199-211.
48. Masoud H, Perry MB, Richards JC. Characterization of the lipopolysaccharide of Moraxella catarrhalis. Structural analysis of the lipid A from M. catarrhalis serotype A lipopolysaccharide. Eur J Biochem 1994; 220:209-16.
49. Hashimoto M, Asai Y, Tamai R, Jinno T, Umatani K, Ogawa T. Chemical structure and immunobiological activity of lipid A from Prevotella intermedia ATCC 25611 lipopolysaccharide. FEBS Lett 2003; 543:98-102.
50. Erridge C, Pridmore A, Eley A, Stewart J, Poxton IR. Lipopolysaccharides of Bacteroides fragilis, Chlamydia trachomatis and Pseudomonas aeruginosa signal via toll-like receptor 2. J Med Microbiol 2004; 53:735-40.
51. Gollwitzer ES, Saglani S, Trompette A et al. Lung microbiota promotes tolerance to allergens in neonates via PD-L1. Nat Med 2014; 20:642-7.
52. Coats SR, Reife RA, Bainbridge BW, Pham TT-T, Darveau RP. Porphyromonas gingivalis lipopolysaccharide antagonizes Escherichia coli lipopolysaccharide at toll-like receptor 4 in human endothelial cells. Infect Immun 2003; 71:6799-807.
53. Coats SR, Pham T-TT, Bainbridge BW, Reife RA, Darveau RP. MD-2 mediates the ability of tetra-acylated and penta-acylated lipopolysaccharides to antagonize Escherichia coli lipopolysaccharide at the TLR4 signaling complex. J Immunol 2005; 175:4490-8.
54. Hernandez ML, Herbst M, Lay JC, Alexis NE, Brickey WJ, Ting JPY, Zhou H, Peden DB. Atopic asthmatic patients have reduced airway inflammatory cell recruitment after inhaled endotoxin challenge compared with healthy volunteers. J Allergy Clin Immunol 2012;130:869-76.
55. Möller W, Heimbeck I, Hofer TPJ, Khadem Saba G, Neiswirth M, Frankenberger M, Ziegler-Heitbrock L. Differential inflammatory response to inhaled lipopolysaccharide targeted either to the airways or the alveoli in man. PLoS One 2012; 7:e33505.